A recent study by Guo (43) revealed that transforming growth factor-beta 1 (TGFβ1) treatment can induce mitochondrial morphologic variations in connection with a shift from epithelial to mesenchymal phenotype of pancreatic cancer cells. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.